ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2021

LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway.

Lei Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.